[144] Xos, Inc. SEC Filing

Rhea-AI Filing Summary

Xos, Inc. (XOS) filed a Form 144 notifying intent to sell 200,000 shares of Common Stock through Piper Sandler & Co. The filing lists an aggregate market value of $616,000 and reports 8,690,583 shares outstanding. The shares were acquired on 08/20/2021 as SPAC merger shares and the proposed approximate sale date is 08/26/2025. The filer reports no securities sold in the past three months and provides the standard representation that the seller is not aware of any undisclosed material adverse information. The filing does not include details on the seller's identity, reason for sale, or any trading plan dates.

Positive

• Transparent disclosure of planned sale quantity, acquisition date, and broker meets Form 144 requirements
• No reported sales in the past three months, which may simplify Rule 144 volume calculations

Negative

• Seller identity is not specified in the provided content, limiting assessment of insider status or governance implications
• No 10b5-1 plan adoption date or trading-plan information is provided, restricting clarity on pre-arranged trading intentions

Insights

Securities Analyst

TL;DR Planned sale of 200,000 XOS shares (~$616k) from SPAC merger holdings appears routine and is disclosed under Rule 144.

The filing documents a proposed sale executed through Piper Sandler & Co. The shares represent a defined quantity relative to the stated outstanding share base; however, the filing lacks the seller's identity, any trading-plan adoption date, and specifics on whether volume limitations or aggregation with other holders apply. No sales in the prior three months are reported, which is relevant for Rule 144 volume calculations. This disclosure meets Form 144 requirements but provides limited investor-impact context.

Corporate Governance Expert

TL;DR Disclosure is compliant but sparse; absence of signer and 10b5-1 plan date limits interpretation of trading intentions.

The form shows acquisition via SPAC merger on 08/20/2021 and a single-broker arrangement for a sale slated ~08/26/2025. From a governance perspective, key contextual items—such as whether the seller is an officer, director, or large insider—are not provided here, constraining assessment of potential signaling or insider liquidity events. The representation about undisclosed material information is included as required.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Piper Sandler & Co Inc 350 N 5th St Ste 1000 Minneapolis MN 55401	200000	616000.00	8690583	08/26/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/20/2021	SPAC Merger Shares	Issuer			200000	08/20/2021	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the XOS Form 144 announce?

It announces a proposed sale of 200,000 shares of Xos, Inc. common stock through Piper Sandler & Co., with an aggregate market value of $616,000.

When were the shares to be sold acquired?

The shares were acquired on 08/20/2021 as SPAC merger shares and payment was recorded on that date.

What is the proposed sale date in the filing?

The filing lists an approximate date of sale of 08/26/2025.

How many XOS shares are outstanding according to the filing?

The filing reports 8,690,583 shares outstanding.

Were any XOS securities sold by this person in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Through which broker will the sale be executed?

The broker named is Piper Sandler & Co. (Minneapolis, MN).